𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Involved field radiotherapy following auto-transplantation for lymphoma and Hodgkin's disease

✍ Scribed by R. Brasacchio; L. Constine; A. Rapoport; J. Rowe; S. Eberly; A. Muhs; P. Rubin


Publisher
Elsevier Science
Year
1994
Tongue
English
Weight
269 KB
Volume
30
Category
Article
ISSN
0360-3016

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


High incidence of secondary myelodysplas
✍ C. Corti; C. Theodore; C. Bayle; P. Rougier; F. Nasr; J. M. Cosset; T Girinsky; πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 316 KB πŸ‘ 2 views

The incidence of secondary myelodysplastic syndromes (MDS) are rarely reported in an homogeneous patient population treated for non-Hodgkin's lymphoma (NHL). Less than 10 per cent of secondary MDS are usually observed in patients treated for Hodgkin's disease and NHL. Data on the incidence of second

Consolidative involved field radiotherap
✍ Christoph Oehler-JΓ€nne; Christian Taverna; Nadine Stanek; Laura Negretti; Urs M. πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 123 KB

## Abstract The role of involved field radiation therapy (IF‐RT) after high dose chemotherapy (HDC) with autologous stem cell transplantation (ASCT) for non‐Hodgkin's lymphoma (NHL) has not been conclusively defined. It has been hypothesized that HDC might obviate the need of consolidative IF‐RT. A